Brief: Carsgen Announces NDA Acceptance Of BCMA Car T Zevor-Cel (Ct053) By China NMPA
18/10/2022 13:52
Oct 18 (Reuters) - CARsgen Therapeutics Holdings Ltd
2171.HK :
* CARSGEN ANNOUNCES NDA ACCEPTANCE OF BCMA CAR T ZEVOR-CEL
(CT053)
BY CHINA NMPA
* CARSGEN THERAPEUTICS HOLDINGS LTD - STUDY RESULTS SHOWED
THAT
ZEVOR-CEL HAS EXCELLENT SAFETY AND EFFICACY PROFILES
Source text for Eikon: ID:nPnHYGTda
Further company coverage: 2171.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CARsgen Therapeutics Holdings
See all newsBrief: Carsgen Therapeutics Says CT1190B Receives IND Clearance From NMPA For Relapsed/Refractory Large B-Cell Lymphoma
Brief: Carsgen Therapeutics Says CT0596 Receives IND Clearance From NMPA
Brief: Carsgen Therapeutics Approves Share Repurchase Plan For Up To 30.12 Million Shares
CARsgen Therapeutics climbs on board nod for share buyback
Brief: Carsgen Therapeutics Says NMPA Approves Satricabtagene Autoleucel For Advanced Gastric Cancer